亚洲欧美一级久久精品,国产特黄一级一片免费,久久久久国产一级毛片高清板,欧美一级片在线免费看,欧美一区二区三区激情视频,美女视频很黄很A免费国产,狠狠久久综合伊人不卡,国内自产拍自A免费毛片,国产美女一级做视频爱

   
   

 
 
     
 
Product Research
Paclitaxel
Docetaxel
Vinorelbine
Ifosfamide
Mesna
Pirarubicin
Aclarubicin
Adriamycin
Daunorubicin
Vincristine
Bleomycin
Lastet



 

Lastat (LAS), or called as, etoposide, epiopodophyllotoxin or VP-16, is the only imported capsule of this breed. It is a breed of “Catalogue of National Essential Drugs” and “Catalogue of National Essential Medical Insurance Drugs”. Etoposide is a kind of anti-tumor drugs which is extracted from podophyllotoxin and treated with chemical synthesis in 1996. It is mainly applied in small cell lung cancer and malignant lymphoma. Its capsule is produced by Nippon Shinyaku Co Ltd, who holds the patent to produce. It is the only corporation in the world to produce this drug of 25 mg specification. Etoposid began to be used in clinical therapy in 1971 and received the FDA license of America in 1983. It is one of the most favorite young anti-tumor drugs currently all around the world. Etoposide is of anti-cancer spectrum, and is effective to malignant blood disease or many kinds of solid tumors. Except this, it can be for oral using, which make it possible to cure tumor in out-patient clinic. It is indicated by some experiments that the anti-neoplasmic activity of etoposide is time dependence. When the total dose is the same, it is more effective to cure in little dose and long time rest and for several times than just once. it is shown by Clinical experiments that use etoposide at 25 mg per time and three times a day for oral use, may get excellent therapy effect with few side effects in curing malignant lymphoma and leukemia. This method is quite suitable to those patients of high years or patients in bad general state or in the late state of illness or drug resistant. It is especially suitable for continuous oral using in small dose, and there’s no idem etalon drugs in the market till now.

Etoposide made by Nippon Shinyaku Co Ltd is sold to tens of countries all around the word such as Asia, Europe and so on. In 1993, it landed china and became the earliest capsule preparation. Since 1995, when we collaborated with association of anticancer drags of Japan to develop China market, this productive has gained grate identification of the clinicians and patients for sound effect. Patients can have chemotherapy in out-patient clinic, so the therapy effect improves with lower side effect.


 
  國家食品藥品監(jiān)督管理局世界衛(wèi)生組織中國醫(yī)學科學院深圳萬維醫(yī)藥貿(mào)易有限公司  
  深圳萬樂藥業(yè)有限公司 版權(quán)所有
Copyright © 2004 Shenzhen Main Luck Phar maceuticals Inc. All right reserved
Email:wanle@wanle.com.cn
 
Home Site Map English Version 主站蜘蛛池模板: 翼城县| 西盟| 崇明县| 遵义市| 平陆县| 清徐县| 崇州市| 汽车| 宁国市| 京山县| 垫江县| 常熟市| 集贤县| 南郑县| 崇明县| 华池县| 延吉市| 常州市| 凤阳县| 称多县| 庆云县| 盖州市| 墨竹工卡县| 文安县| 赤峰市| 大姚县| 巴楚县| 毕节市| 屏东市| 潮安县| 靖宇县| 广丰县| 南靖县| 湘潭市| 疏勒县| 景洪市| 板桥市| 和林格尔县| 潢川县| 淅川县| 鄱阳县|